PE  Soleus Capital

http://soleuscapital.com/





     Office Locations:

104 Field Point Rd, 2nd Floor
Greenwich, CT 06830
Phone: 475-208-3178

 

Stages:

  • Middle Market


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Soleus Capital Management is a private equity firm focused on investing within the healthcare sector. According to an SEC filing, the firm recently raised $39.55 million for its debut private equity fund. The target amount is $125 million.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Guy Bezalel Levy CIO
    Lennox Ketner Managing Director
    Steven Joseph Musumeci J.D. CCO
    Zachary Williams Analyst

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      05/21/2024


      AltruBio


      CA


      $225,000,000


      Series B


      12/14/2023


      Parse Biosciences


      WA


      $50,000,000


      Series C


     

    Portfolio companies include:


      AltruBio
        web link


      Antios Therapeutics
        web link


      BioAtla
        web link


      DiCE Molecules
        web link


      Genapsys
        web link


      InBrace
        web link


      Lyra Therapeutics


      NeuroPace
        web link


      Orchestra BioMed
        web link


      Parse Biosciences
        web link


     

    Recent News: